Study on interleukin 1 signal transduction
Study on interleukin 1 signal transduction
批准号:
08457614
负责人:
ONOZAKI Kikuo
金额:
$1.15万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
IL-1在宿主的免疫、炎症和血液学反应中发挥重要作用,并调节细胞增殖和分化。在本研究中,我们分析了IL-1信号传导导致人类黑色素瘤细胞增殖抑制的机制。(A375.1)IL-1似乎通过增加鸟氨酸脱羧酶(ODC)的调节因子AZ来抑制细胞增殖,无论是转录水平还是后转录水平,而不是移码。IL-1还上调p38MAPK的活性,从而在转录后水平上调控AZ的水平。细胞周期调节因子p53、p21和p16的表达水平以及Rb的磷酸化水平均不受IL-1的影响。1.2)通过IL-1敏感细胞和IL-1耐药细胞杂交发现,对IL-1的抗性是隐性的。相比之下,在IL-1抗性细胞中观察到的IL-1 α和IL-6的组成性产生占主导地位。因此,在耐药细胞中,导致il -1诱导的细胞增殖抑制的信号是缺乏的。3)与敏感细胞相比,IL-1耐药细胞的细胞粘附分子、IL-8和基质金属蛋白酶的产生、对基质的侵袭性等已报道的人类黑色素瘤恶性特征均有所增加。因此,IL-1耐药细胞似乎是研究人类黑色素瘤恶性机制的一个很好的模型。4) LPS可提高小鼠肝脏中IL-1RI mRNA的表达水平。在该模型中,IL-1、IL-6和糖皮质激素(GC)似乎发挥了重要作用。GC和IL-6均可增加肝细胞表面IL-1RI分子的数量。
英文摘要
IL-1 plays an important role in host reactions, including immunologic, inflammatory and hematologic reactions, and in regulation of cell proliferation and differentiation. In this study we analyzed the mechanism of IL-1 signaling leading to the inhibition of cell proliferation of human melanoma cells A375.1)IL-1 appeared to inhibit the cell proliferation by an increase of AZ,a reguratory factor of ornithine decarboxylase (ODC), both in the levels of transcription and posttranscription other than frameshift. IL-1 also upregulated the activity of p38MAPK which regulated AZ level at the level of posttranscription. The expression levels of cell cycle-regulatory factors, p53, p21 and p16, as well as phosphorylation levels of Rb were not influenced by IL-1.2)By cell hybridization between IL-1 sensitive and resistant cells, resistance to IL-1 appeared to be recessive. In contrast, the constitutive production of IL-1alpha and IL-6 observed in IL-1 resistant cells was dominant. Therefore, in resistant cells the signaling leading to IL-1-induced inhibition of cell proliferation is deficient.3)The characteristics of reported malignant characteristics in human melanoma, including cell adhesion molecules, production of IL-8 and matrix metalloproteinases, invasiveness into matrigel were all incresed in IL-1 resistant cells compared to those of sensitive cells. Therefore, the IL-1 resistant cells apperaed to be a very good model to investigate the mechanism of malignancy of human melanomas.4)By administration of LPS into mice, the expression level of IL-1RI mRNA in the liver was augmented. In this model, IL-1, IL-6 and glucocorticoid (GC) appeared to play an important role. Furthermore, the number of IL-1RI molecule on the cell surface of hepatocytes was increased by treatment with GC and IL-6.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A.Ito, T.Takii, N.Goto, Y.Kito, K.Onozaki: "Role of glucocorticoid in the upregulation of type I interleukin-1 receptor mRNA expression in hepatocytes of endotoxin-administrated mice." Journal of Interferon and Cytokine Research. 17(7). 413-417 (1997)
A.Ito、T.Takii、N.Goto、Y.Kito、K.Onozaki:“糖皮质激素在上调内毒素小鼠肝细胞 I 型白细胞介素 1 受体 mRNA 表达中的作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Itoh, H.Hayashi, N.Watanabe, Y.Kobayashi, T.Takii, K.Onozaki.: "Interleukin 1(IL-1) production is not essential for acquired resistance of human melanoma cells A375 to anti-proliferative effect of IL-1." International Journal of Cancer. 65. 805-811 (199
S.Itoh、H.Hayashi、N.Watanabe、Y.Kobayashi、T.Takii、K.Onozaki.:“白细胞介素 1 (IL-1) 的产生对于人黑色素瘤细胞 A375 抗增殖作用的获得性抵抗并不重要
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Itoh, H.Hayashi, D.Yang T.Takii, K.Onozaki: "Acquired resistance to the anti-[roliferative effect of IL-1 and IL-6 is a recessive phenotype in A375 human melanoma cells" Melanoma Research. 7. 455-462 (1997)
S.Itoh、H.Hayashi、D.Yang T.Takii、K.Onozaki:“对 IL-1 和 IL-6 的抗增殖作用的获得性抵抗是 A375 人黑色素瘤细胞的隐性表型”黑色素瘤研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Ito, T.Takii, N.Goto, Y.Kito K.Onozaki: "Role of glucocorticoid in the upregulation of type I interleukin-1 receptor mRNA expression in hepatocytes of endotoxin-administrated mice." Journal of Interferon and Cytokine Research. 17(7). 413-417 (1997)
A.Ito、T.Takii、N.Goto、Y.Kito K.Onozaki:“糖皮质激素在上调内毒素小鼠肝细胞中 I 型白细胞介素 1 受体 mRNA 表达中的作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Itoh, H.Hayashi, D.Yang, T.Takii, K.Onozaki: "Acquired resistance to the anti-proliferative effect of IL-1 and IL-6 is a recessive phenotype in A375 human melanoma cells" Melanoma Research. 7. 455-462 (1997)
S.Itoh、H.Hayashi、D.Yang、T.Takii、K.Onozaki:“对 IL-1 和 IL-6 的抗增殖作用的获得性抵抗是 A375 人黑色素瘤细胞的隐性表型”黑色素瘤研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
Regulatory mechanism of the induction and function of IL-1
-
批准号:20590064
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:ONOZAKI Kikuo
-
依托单位:
Study on the action mechanism of IL-1 and its regulation
-
批准号:14370750
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:2002
-
负责人:ONOZAKI Kikuo
-
依托单位:
The mechanism and its regulation of interleukin 1 biological activities
-
批准号:11470487
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.27万
-
财政年份:1999
-
负责人:ONOZAKI Kikuo
-
依托单位:
Development of IL-1 with selective activities by introduction of carbohydrates
-
批准号:07557159
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$4.8万
-
财政年份:1995
-
负责人:ONOZAKI Kikuo
-
依托单位:
Study on the interleukin-1 signaling
-
批准号:06672194
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:ONOZAKI Kikuo
-
依托单位:
The mechanism of the acquired resistance to the anti-proliferative effect of IL-1 on human melanoma cells.
-
批准号:04671364
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1992
-
负责人:ONOZAKI Kikuo
-
依托单位:
Study on the Interleukin 1 Growth-Regulatory Activity.
-
批准号:01571233
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:ONOZAKI Kikuo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
机械应力触发IL-1R/Piezo1正反馈环路诱导颞下颌关节髁突软骨细胞衰老的机制
-
批准号:82371002
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:白丁
-
依托单位:
CD4+CXCR5+PD-1+Foxp3+滤泡调节性T细胞通过IL-1R/Ra途径调控Tfh细胞在MOG抗体相关疾病发病机制中的作用
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:全超
-
依托单位:
IL-1/IL-1R在急性炎症中对髓系造血的调控作用及机制研究
-
批准号:82100225
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:张潇予
-
依托单位:
IL-1β/IL-1R 通路介导的调节性 B 细胞在颅内动脉瘤中的作用和机制研究
-
批准号:LBY22H200004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:施婵宏
-
依托单位:
基于促炎型巨噬细胞和自然杀伤细胞关系研究丹参调节NLRP3/IL-1R/MAPK信号通路抗肝纤维化的作用机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:彭渊
-
依托单位:
IL-1β/IL-1R介导的小胶质细胞衰老在EAE小鼠认知障碍中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:陈晓红
-
依托单位:
IL-1β-IL-1R放大环路促进ALA-PDT治疗皮肤鳞癌的效应与机制研究
-
批准号:81572671
-
项目类别:面上项目
-
资助金额:42.0万元
-
批准年份:2015
-
负责人:王宏伟
-
依托单位:
IRAK1单倍型介导IL-1R/TLR信号调节Th17功能异常在SLE发病中的作用及机制
-
批准号:81472883
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2014
-
负责人:郝飞
-
依托单位:
性激素及IL-1/IL-1R通路在原发性肝癌发生中的作用
-
批准号:81072029
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:孙倍成
-
依托单位:
mTOR在TLR和IL-1R信号中调节炎症相关性癌症的机理研究
-
批准号:31070779
-
项目类别:面上项目
-
资助金额:40.0万元
-
批准年份:2010
-
负责人:肖晖
-
依托单位: